Rocket Pharmaceuticals (NASDAQ:RCKT) Price Target Raised to $30.00
Rocket Pharmaceuticals (NASDAQ:RCKT – Free Report) had its price target increased by Cantor Fitzgerald from $20.00 to $30.00 in a research report sent to investors on Friday morning,Benzinga reports. They currently have an overweight rating on the biotechnology company’s stock. Cantor Fitzgerald also issued estimates for Rocket Pharmaceuticals’ FY2025 earnings at ($2.28) EPS. RCKT has […]
Rocket Pharmaceuticals (NASDAQ:RCKT – Free Report) had its price target increased by Cantor Fitzgerald from $20.00 to $30.00 in a research report sent to investors on Friday morning,Benzinga reports. They currently have an overweight rating on the biotechnology company’s stock. Cantor Fitzgerald also issued estimates for Rocket Pharmaceuticals’ FY2025 earnings at ($2.28) EPS. RCKT has […]
